# Pasithea Therapeutics Corp.: filings

KTTA · Nasdaq · CIK 1841330 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ktta.md) · [Financials](/companies/ktta/financials.md) · [Filings](/companies/ktta/filings.md) · [Insiders](/companies/ktta/insiders.md)

## Reports and events: 95 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 50, 8-K 41, CORRESP 24, 3 19, 10-Q 15, UPLOAD 14, 424B3 11, SCHEDULE 13G 11, DEFA14A 10, DFAN14A 9, EFFECT 9, SC 13D/A 9, SCHEDULE 13G/A 9, 4/A 8, S-1/A 7, DEF 14A 6, PRE 14A 6, SC 13G 6, 10-K 5, S-8 5, SC 13G/A 5, ARS 4, DEFC14A 4, PREC14A 4, S-1 4, SC TO-I/A 4, 3/A 3, 424B4 3, 8-K/A 3, D 3, FWP 3, S-3 3, 10-K/A 2, 424B5 2, DRS 2, POS AM 2, PRRN14A 2, SC 13D 2, 144 1, 25-NSE 1, 8-A12B 1, CERT 1, DEL AM 1, DRSLTR 1, NT 10-Q 1, PRER14A 1, S-1MEF 1, SCHEDULE 13D/A 1, SC TO-C 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-16 | 16:06 ET | [8-K](/filings/0001213900-26-100515.md) | 8.01 Other events | 0001213900-26-100515 |
| 2026-09-09 | 16:20 ET | [8-K](/filings/0001213900-26-098405.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-098405 |
| 2026-08-21 | 17:05 ET | [8-K](/filings/0001213900-26-092672.md) | 3.01 Delisting notice | 0001213900-26-092672 |
| 2026-08-14 | 16:30 ET | [10-Q](/filings/0001213900-26-090146.md) | Quarterly report, period 2026-06-30 | 0001213900-26-090146 |
| 2026-08-07 | 17:15 ET | [DEF 14A](/filings/0001213900-26-086799.md) | Proxy statement, period 2026-09-09 | 0001213900-26-086799 |
| 2026-05-15 | 16:30 ET | [10-Q](/filings/0001213900-26-057837.md) | Quarterly report, period 2026-03-31 | 0001213900-26-057837 |
| 2026-05-04 | 17:00 ET | [8-K](/filings/0001213900-26-051681.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-051681 |
| 2026-03-30 | 17:33 ET | [10-K](/filings/0001213900-26-036434.md) | Annual report, period 2025-12-31 | 0001213900-26-036434 |
| 2026-02-20 | 17:00 ET | [8-K](/filings/0001213900-26-018874.md) | 3.01 Delisting notice | 0001213900-26-018874 |
| 2026-01-28 | 16:15 ET | [8-K](/filings/0001213900-26-008828.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-008828 |
| 2025-12-29 | 17:00 ET | [DEF 14A](/filings/0001213900-25-126111.md) | Proxy statement, period 2026-01-28 | 0001213900-25-126111 |
| 2025-12-15 | 08:00 ET | [8-K](/filings/0001213900-25-121466.md) | 8.01 Other events | 0001213900-25-121466 |
| 2025-12-02 | 09:23 ET | [8-K](/filings/0001213900-25-116985.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-116985 |
| 2025-11-26 | 17:04 ET | [S-1/A](/filings/0001213900-25-115595.md) | Registration statement, amended | 0001213900-25-115595 |
| 2025-11-25 | 16:15 ET | [8-K](/filings/0001213900-25-114763.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-114763 |
| 2025-11-18 | 10:50 ET | [S-1](/filings/0001213900-25-111842.md) | Registration statement | 0001213900-25-111842 |
| 2025-11-13 | 17:01 ET | [10-Q](/filings/0001213900-25-110093.md) | Quarterly report, period 2025-09-30 | 0001213900-25-110093 |
| 2025-11-04 | 07:04 ET | [8-K](/filings/0001213900-25-105599.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-105599 |
| 2025-10-27 | 17:25 ET | [8-K](/filings/0001213900-25-102673.md) | 5.02 Departure or appointment of officers or directors | 0001213900-25-102673 |
| 2025-09-16 | 07:04 ET | [8-K](/filings/0001213900-25-087903.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-087903 |
| 2025-09-03 | 16:30 ET | [8-K](/filings/0001213900-25-084062.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-084062 |
| 2025-08-14 | 15:44 ET | [10-Q](/filings/0001213900-25-076557.md) | Quarterly report, period 2025-06-30 | 0001213900-25-076557 |
| 2025-07-24 | 16:15 ET | [DEF 14A](/filings/0001213900-25-067344.md) | Proxy statement, period 2025-09-03 | 0001213900-25-067344 |
| 2025-07-11 | 16:15 ET | [8-K](/filings/0001213900-25-063277.md) | 5.08 Item not in the standard list | 0001213900-25-063277 |
| 2025-06-27 | 16:05 ET | [8-K](/filings/0001213900-25-059004.md) | 3.01 Delisting notice | 0001213900-25-059004 |
| 2025-06-20 | 16:20 ET | [8-K](/filings/0001213900-25-056209.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-056209 |
| 2025-05-15 | 16:31 ET | [10-Q](/filings/0001213900-25-044281.md) | Quarterly report, period 2025-03-31 | 0001213900-25-044281 |
| 2025-05-07 | 17:18 ET | [8-K](/filings/0001213900-25-040725.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-040725 |
| 2025-05-01 | 09:27 ET | [S-1](/filings/0001213900-25-038088.md) | Registration statement | 0001213900-25-038088 |
| 2025-04-25 | 17:02 ET | [8-K](/filings/0001213900-25-035640.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-035640 |
| 2025-03-24 | 16:55 ET | [10-K](/filings/0001013762-25-001646.md) | Annual report, period 2024-12-31 | 0001013762-25-001646 |
| 2025-03-06 | 21:55 ET | [SCHEDULE 13D/A](/filings/0001013762-25-000233.md) | Ownership report, active investor, amended | 0001013762-25-000233 |
| 2024-11-26 | 17:00 ET | [8-K](/filings/0001213900-24-102903.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-102903 |
| 2024-11-13 | 16:30 ET | [10-Q](/filings/0001213900-24-097496.md) | Quarterly report, period 2024-09-30 | 0001213900-24-097496 |
| 2024-09-30 | 16:49 ET | [8-K](/filings/0001213900-24-083408.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-083408 |
| 2024-09-26 | 08:45 ET | [8-K](/filings/0001213900-24-081982.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-081982 |
| 2024-08-13 | 16:30 ET | [10-Q](/filings/0001213900-24-068297.md) | Quarterly report, period 2024-06-30 | 0001213900-24-068297 |
| 2024-06-26 | 17:00 ET | [8-K](/filings/0001213900-24-056205.md) | 5.07 Shareholder vote results | 0001213900-24-056205 |
| 2024-05-28 | 09:00 ET | [DEF 14A](/filings/0001213900-24-046814.md) | Proxy statement, period 2024-06-26 | 0001213900-24-046814 |
| 2024-05-14 | 17:15 ET | [8-K](/filings/0001213900-24-043036.md) | 5.08 Item not in the standard list | 0001213900-24-043036 |
| 2024-05-14 | 16:31 ET | [10-Q](/filings/0001213900-24-042981.md) | Quarterly report, period 2024-03-31 | 0001213900-24-042981 |
| 2024-03-29 | 20:11 ET | [10-K](/filings/0001213900-24-027508.md) | Annual report, period 2023-12-31 | 0001213900-24-027508 |
| 2024-01-18 | 16:30 ET | [8-K](/filings/0001213900-24-004520.md) | 8.01 Other events | 0001213900-24-004520 |
| 2024-01-02 | 16:47 ET | [8-K](/filings/0001213900-24-000296.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-000296 |
| 2023-12-28 | 11:30 ET | [8-K](/filings/0001213900-23-099115.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-23-099115 |
| 2023-12-19 | 17:21 ET | [8-K](/filings/0001213900-23-097013.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-23-097013 |
| 2023-11-13 | 16:45 ET | [10-Q](/filings/0001213900-23-086198.md) | Quarterly report, period 2023-09-30 | 0001213900-23-086198 |
| 2023-10-26 | 17:00 ET | [DEF 14A](/filings/0001013762-23-006985.md) | Proxy statement, period 2023-11-29 | 0001013762-23-006985 |
| 2023-10-13 | 17:00 ET | [8-K](/filings/0001013762-23-003856.md) | 5.08 Item not in the standard list | 0001013762-23-003856 |
| 2023-09-14 | 09:11 ET | [8-K](/filings/0001213900-23-076515.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-076515 |

Page 1 of 2. [Older](/companies/ktta/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.